The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBraveheart Inv Regulatory News (BRH)

Share Price Information for Braveheart Inv (BRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 5.00
Bid: 4.00
Ask: 6.00
Change: 0.00 (0.00%)
Spread: 2.00 (50.00%)
Open: 5.00
High: 5.00
Low: 5.00
Prev. Close: 5.00
BRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Notice of General Meeting

18 Jun 2018 07:02

RNS Number : 6273R
Braveheart Investment Group plc
18 June 2018
 

18 June 2018

 

Braveheart Investment Group plc

("Braveheart", the "Company" or the "Group")

 

Notice of GM

Proposed Reduction of Share Capital

 

 

Braveheart Investment Group plc (AIM: BRH), the fund management and strategic investor group, announces that it proposes to carry out a capital reduction by cancelling the whole of its share premium account thereby enabling the Directors to consider the payment of dividends to its shareholders as a means of returning income to shareholders should the Directors consider it is appropriate to do so.

 

A General Meeting is being convened to be held on 19 July 2018 at 11.30 a.m. (or immediately following the conclusion or adjournment of the Annual General Meeting called at 11.00 a.m. on that date) at the offices of Edwin Coe, 2 Stone Buildings, Lincoln's Inn, London WC2A 3TH ("the General Meeting") in order to consider, and if thought fit, pass the resolution necessary to implement the proposal.

 

The Company's 2018 Annual Report and Accounts show its total liabilities as at 31 March 2018 as £1,434,382, and its retained earnings as at that date as £33,293. However, the retained earnings include unrealised profits of circa £270,000 and do not include contingent liabilities of £147,982. Consequently, the Company does not have any distributable profits and is unable to declare dividends.

 

At the same time, the Company's accounts show a sum of £1,567,615 standing to the credit of its share premium account. The share premium account is an undistributable reserve and, accordingly, the purposes for which a company can use the sums credited to this reserve are very limited. However, with the consent of its shareholders and the approval of the Court, a company may reduce or cancel its share premium account and the reserve arising on such a reduction of capital may be used in diminishing or extinguishing a deficit or maximising returns to shareholders.

 

The Company therefore proposes to cancel the whole of its share premium account in order to generate distributable reserves of approximately £1.295 million, which would enable the Company to pay dividends (should circumstances in the future make it desirable to do so) to the extent of the distributable reserves created but subject to the financial position of the Company and its prospects at the relevant time and any undertakings given to the Court for the protection of the Company's creditors at the date that the Capital reduction becomes effective.

 

The cancellation of the Company's share premium account will only take effect if sanctioned by the Shareholders at the General Meeting and confirmed by the Court and upon the appropriate documents being lodged with the Registrar of Companies.

 

An application to the Court will be made as soon as practicable after the passing of the required shareholder resolution and the procedure is expected to be completed within six to eight weeks following the passing of the required shareholder resolution.

 

The Directors have been advised that, having regard to the circumstances at the date of this document, the Court is expected to confirm the Capital Reduction. The Directors are not, however, able to guarantee the Court's confirmation of the Capital Reduction. It is important to note that the Capital Reduction will not take effect unless it is confirmed by the Court.

 

The Directors have also been advised that the Court may require that the Company give undertakings for the protection of the Company's creditors at the date that the Capital Reduction becomes effective.

 

As at 31 March 2018, the Company's liabilities (including contingent liabilities) amounted to a total of approximately £1,582,274, of which (i) £147,892 relates to contingent liabilities arising under the guarantees provided by the Company pursuant to section 479 of the Companies Act and (ii) the balance of £1,434,382 relates to debts owed by the Company. The majority of its creditors consist of subsidiaries of the Company, in respect of which there are debts of £1,371,373 and contingent liabilities of £105,841. The relevant subsidiaries of the Company have indicated that they will consent to the Capital Reduction to generate distributable reserves and agree not to seek repayment of the sums due to them until such time as the sums due to the balance of the creditors (the "Remaining Creditors") at the date on which the capital reduction takes effect (the "Effective Date") have been repaid in full. The Remaining Creditors at the Effective Date are due to be paid a total amount of approximately £63,000 and there are contingent liabilities to Remaining Creditors of approximately £42,000.

 

The Company will if required give an undertaking to the Court that the part of the distributable reserves created by the Capital Reduction equal to the sums due to the Remaining Creditors at the Effective Date will not be used for any other purposes without paying those Remaining Creditors the sums due to them on the Effective Date, except to the extent that the Remaining Creditors consent to those distributable reserves being used for other purposes.

 

A notice convening a General Meeting to consider and, if thought fit, pass the necessary resolution will be set out in a Circular which will be sent to shareholders shortly and will be available on the Company's website www.braveheartgroup.co.uk.

 

 

For further information:

 

Braveheart Investment Group plc +44 (0) 1738 587555

Trevor Brown, Chief Executive

 

Allenby Capital Limited (Nominated Adviser and Broker) +44 (0) 20 3328 5656

David Worlidge / Nicholas Chambers

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NOGBLGDLSUBBGIU
Date   Source Headline
19th Jul 201812:15 pmRNSResult of AGM and GM
16th Jul 20187:00 amRNSUpdate on fund management business
12th Jul 20187:00 amRNSProposed funding round by Paraytec Limited
10th Jul 201810:44 amRNSHolding(s) in Company
25th Jun 20187:00 amRNSFurther re. Notice of Annual General Meeting
21st Jun 20185:16 pmRNSConfirmation of Posting
20th Jun 201810:30 amRNSAppointment of Joint Broker
18th Jun 20187:02 amRNSNotice of General Meeting
18th Jun 20187:00 amRNSFinal Results
26th Apr 20187:00 amRNSTrading Update
9th Apr 20185:11 pmRNSThird party investment into Gyrometric Systems Ltd
16th Jan 20184:24 pmRNSChange of Registered Office
19th Oct 20177:00 amRNSHalf-year Report
13th Sep 20177:00 amRNSUpdate re. Portfolio investment
1st Sep 20177:00 amRNSRetirement of Director and Total Voting Rights
8th Aug 20177:00 amRNSIssue of Equity
20th Jul 201711:19 amRNSResult of AGM
20th Jul 20177:00 amRNSAGM Statement
21st Jun 20177:00 amRNSFinal Results for the year ended 31 March 2017
7th Jun 20174:08 pmRNSDirectorate Change
20th Apr 20177:00 amRNSTrading Update
9th Jan 20177:00 amRNSStrategic Investment and Trading Update
12th Oct 20167:00 amRNSHalf-year Report
16th Sep 201611:18 amRNSDisposal of interest in Investee Company
2nd Aug 201612:08 pmRNSConditional disposal of interest-Investee Company
29th Jul 201611:13 amRNSStmnt re Share Price Movement
26th Jul 20169:32 amRNSHolding(s) in Company
19th Jul 201611:46 amRNSResult of AGM
19th Jul 20167:00 amRNSAGM Statement
13th Jul 20163:26 pmRNSDirectors' Dealings
8th Jul 20163:07 pmRNSInvestment in Kirkstall Limited
4th Jul 20167:00 amRNSInvestment in Paraytec Limited
23rd Jun 20168:45 amRNSAnnual Results
3rd Mar 20167:00 amRNSChange of Nomad & Broker and Directorate Changes
15th Jan 20169:36 amRNSDirectors' Dealings
8th Jan 201612:36 pmRNSDisposal of interest in WhiteRock Capital Partners
15th Dec 20152:33 pmRNSCompletion of sale of interest in Biopta
27th Nov 20157:00 amRNSDisposal of interest in Investee Company
2nd Nov 20152:35 pmRNSHalf Yearly Report & Disposal
24th Sep 201512:15 pmRNSResult of AGM and Directorate Change
3rd Sep 20157:00 amRNSDirector/PDMR Shareholding
2nd Sep 201512:30 pmRNSPosting of Results and Notice of AGM
24th Aug 20157:00 amRNSPreliminary Results and Board Changes
26th Jun 20152:20 pmRNSChange of address and registered office
6th May 20157:01 amRNSCompletion of restructuring and Directorate change
30th Apr 201511:21 amRNSBraveheart enters into partnership with Seedrs
30th Apr 20157:00 amRNSTermination of partnership
20th Apr 20157:00 amRNSDirectorate Change
23rd Dec 20147:00 amRNSRealisation of Investment
15th Dec 20147:00 amRNSHalf Yearly Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.